Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Welltower Inc. Common Stock (WELL) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Welltower Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Welltower Inc. Common Stock — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13.07 (market cap $763.64M), while Welltower Inc. Common Stock trades at $227.24 (market cap $159.33B). The key difference: Welltower Inc. Common Stock is far larger — about 208.6× Ginkgo Bioworks Holdings Inc's market cap, and Welltower Inc. Common Stock pays a 1.54% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Welltower Inc. Common Stock for 1 Days on average.

DNAWELL
Market Cap
$763.64M$159.33B
Volume
3,204,1772,484,986
Sector
HealthReal Estate
52-Week High
$15.83$252.07
52-Week Low
$5.48$165.94
Typical Hold Time
7 Days1 Days
Enterprise Value
$865.59M$177.09B
Dividend Yield
—1.54%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $12.84, up 11.94% in the last session. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million in 2025 on $170.16 million revenue, with a negative net margin of 219.6%. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting strategic growth initiatives despite financial challenges.

Outlook remains speculative with high risk. The buy/hold/sell analyst split is nearly even, reflecting uncertainty. Significant cash burn and persistent losses pose substantial risks, but partnerships and government contracts offer potential catalysts. Investors should weigh the company's long-term biotechnology prospects against its current lack of profitability and negative cash flow.

Welltower Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
WELL

No sentiment data available yet.

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About Welltower Inc. Common Stock

Welltower is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, outpatient medical facilities, and other health-related real estate.

Read more on WELL →